NCT05768399 The Role of Biomarkers in the Occurrence and Development of Asthma
| NCT ID | NCT05768399 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Chongqing Medical University |
| Condition | Asthma in Children |
| Study Type | OBSERVATIONAL |
| Enrollment | 2 participants |
| Start Date | 2023-07-04 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2 participants in total. It began in 2023-07-04 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To study the expression level of biomarkers such as GITRL in peripheral blood of children with asthma and analyze their correlation with the severity of asthma. To study the predictive value of biomarkers level for the occurrence and development of asthma. And to provide supplementary detection means and predictive indicators for the diagnosis of asthma and the severity of asthma.
Eligibility Criteria
Inclusion Criteria: * In line with the diagnostic criteria in the Guidelines for the Diagnosis and Prevention of Bronchial Asthma in Children (2016 Edition) * Age: 4-12 years old for new diagnosis or recurrent episodes * Typical clinical manifestations and complete clinical data * Family members or guardians of children with informed research and signed consent * All healthy control subjects had no history of lung disease, allergic rhinitis or any other atopic disease Exclusion Criteria: * Suffering from other respiratory diseases (such as bronchiectasis, allergic rhinitis, respiratory failure, tuberculosis, obstructive airway disease) or other inflammatory diseases. * Abnormal development of congenital airway and lung tissue * History of immunosuppressant or glucocorticoid use in the first 4 weeks * Suffering from other endocrine system and immune system diseases * Incomplete clinical data or examinations.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05768399 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 12 Years, studying Asthma in Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05768399 currently recruiting?
Yes, NCT05768399 is actively recruiting participants. Contact the research team at dingfengxia305@163.com for enrollment information.
Where is the NCT05768399 trial being conducted?
This trial is being conducted at Chongqing, China.
Who is sponsoring the NCT05768399 clinical trial?
NCT05768399 is sponsored by Children's Hospital of Chongqing Medical University. The trial plans to enroll 2 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.